Dr. Thomas Durcan is the Director of the Early Drug Discovery Unit at the Montreal Neurological Institute and an Associate Professor at McGill University. He oversees a team of 40+ research staff and students, committed to applying patient-derived stem cells towards the development of phenotypic discovery assays and 3D neuronal organoid models for neurodegenerative and neurodevelopmental disorders. Their long-term strategy is to identify new personalized precision therapies that can be applied toward building clinical trials on a dish.\

Listen to the episode here.